Amplia Therapeutics Limited (ASX:ATX)
Australia · Delayed Price · Currency is AUD 0.1350
0.00 (0.00%)
May 29, 2026, 4:10 PM AEST
Amplia Therapeutics Market Cap
Amplia Therapeutics has a market cap or net worth of 69.26 million as of May 29, 2026. Its market cap has increased by 243.34% in one year.
Market Cap
69.26M
Enterprise Value
41.75M
Revenue
5.49M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.14
Market Cap Chart
Since December 23, 2013, Amplia Therapeutics's market cap has increased from 34.50M to 69.26M, an increase of 100.79%. That is a compound annual growth rate of 5.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 69.26M | -10.00% |
| Dec 31, 2025 | 76.96M | 122.90% |
| Dec 31, 2024 | 34.53M | 122.47% |
| Dec 28, 2023 | 15.52M | - |
| Dec 29, 2022 | 15.52M | -51.48% |
| Dec 31, 2021 | 31.99M | 24.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alterity Therapeutics | 97.88M |
| Paradigm Biopharmaceuticals | 91.95M |
| Arovella Therapeutics | 85.82M |
| Prescient Therapeutics | 82.02M |
| Immutep | 78.11M |
| Radiopharm Theranostics | 70.88M |
| LTR Pharma | 67.26M |
| Cynata Therapeutics | 66.95M |